Prehospital Tranexamic Acid Combined with Blood Transfusion Reduced the Short-Term Mortality Risk in Trauma Patients at Risk for Hemorrhage

Zheng Qian, Bining Yang Department of Emergency Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, People’s Republic of ChinaCorrespondence: Zheng Qian, Department of Emergency Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), No. 9 Chongwen Road, Suzhou Industrial Park, Suzhou, 215000, People’s Republic of China, Email [email protected]: Hemorrhage is a leading cause of preventable death in trauma. While both blood transfusion and tranexamic acid (TXA) improve outcomes, the combined effect of prehospital TXA and transfusion remains uncertain. This study aims to evaluate the impact of prehospital TXA combined with blood transfusion on short-term mortality in trauma patients at risk for hemorrhage.Methods: We performed a retrospective cohort study of 408 adult trauma patients at risk for hemorrhage admitted between 2018 and 2023. Patients were grouped into transfusion only (n=240) or prehospital TXA plus transfusion (n=168). The primary outcome was 30-day mortality. Secondary outcomes included 24-hour mortality, transfusion requirements, multiple organ failure (MOF), and venous thromboembolism (VTE).Results: Compared with transfusion alone, prehospital TXA plus transfusion significantly reduced 30-day mortality (14.3% vs 31.3%, p< 0.01) and 24-hour mortality (6.0% vs 19.6%, p< 0.01). The TXA group also had lower MOF incidence (14.3% vs 28.7%, p< 0.01) and required less plasma and crystalloid resuscitation, without an increase in VTE (p=0.17). Kaplan–Meier analysis confirmed a survival advantage (log-rank p< 0.01), and multivariate Cox regression identified combination therapy as an independent predictor of reduced 30-day mortality (HR=2.16, 95% CI: 1.35– 3.46, p< 0.01).Conclusion: Prehospital TXA combined with transfusion significantly improves short-term survival and reduces organ failure in bleeding trauma patients, without increasing thromboembolic risk. These findings support early integration of TXA into prehospital transfusion protocols.Keywords: trauma, hemorrhage, tranexamic acid, blood transfusion, short-term mortality

Authors

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-12-01
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prehospital Tranexamic Acid Combined with Blood Transfusion Reduced the Short-Term Mortality Risk in Trauma Patients at Risk for Hemorrhage

Yang B, Qian Z
SHILAP Revista de lepidopterología
Blood transfusion and management
article

Prehospital Tranexamic Acid Combined with Blood Transfusion Reduced the Short-Term Mortality Risk in Trauma Patients at Risk for Hemorrhage

Yang B, Qian Z
article en

Abstract

Zheng Qian, Bining Yang Department of Emergency Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, People’s Republic of ChinaCorrespondence: Zheng Qian, Department of Emergency Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), No. 9 Chongwen Road, Suzhou Industrial Park, Suzhou, 215000, People’s Republic of China, Email [email protected]: Hemorrhage is a leading cause of preventable death in trauma. While both blood transfusion and tranexamic acid (TXA) improve outcomes, the combined effect of prehospital TXA and transfusion remains uncertain. This study aims to evaluate the impact of prehospital TXA combined with blood transfusion on short-term mortality in trauma patients at risk for hemorrhage.Methods: We performed a retrospective cohort study of 408 adult trauma patients at risk for hemorrhage admitted between 2018 and 2023. Patients were grouped into transfusion only (n=240) or prehospital TXA plus transfusion (n=168). The primary outcome was 30-day mortality. Secondary outcomes included 24-hour mortality, transfusion requirements, multiple organ failure (MOF), and venous thromboembolism (VTE).Results: Compared with transfusion alone, prehospital TXA plus transfusion significantly reduced 30-day mortality (14.3% vs 31.3%, p< 0.01) and 24-hour mortality (6.0% vs 19.6%, p< 0.01). The TXA group also had lower MOF incidence (14.3% vs 28.7%, p< 0.01) and required less plasma and crystalloid resuscitation, without an increase in VTE (p=0.17). Kaplan–Meier analysis confirmed a survival advantage (log-rank p< 0.01), and multivariate Cox regression identified combination therapy as an independent predictor of reduced 30-day mortality (HR=2.16, 95% CI: 1.35– 3.46, p< 0.01).Conclusion: Prehospital TXA combined with transfusion significantly improves short-term survival and reduces organ failure in bleeding trauma patients, without increasing thromboembolic risk. These findings support early integration of TXA into prehospital transfusion protocols.Keywords: trauma, hemorrhage, tranexamic acid, blood transfusion, short-term mortality

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 41%
Blood transfusion and management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.